Advertisement

Ads Placeholder
Loading...

Embecta Corp.

EMBC•NASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$8.85
$0.06(0.68%)
U.S. Market opens in 0h 57m

Embecta Corp. (EMBC) Stock Overview

Explore Embecta Corp.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap524.1M
P/E Ratio3.70
EPS (TTM)$2.36
ROE-0.21%
Fundamental Analysis

AI Price Forecasts

1 Month$8.70
3 Months$3.99
1 Year Target$10.74

EMBC Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Embecta Corp. (EMBC) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 39.22, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $10.74.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 3.70 and a market capitalization of 524.1M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
0.68%
5-Day Change
0.45%
1-Month Change
-8.86%
3-Month Change
-24.10%
6-Month Change
-38.20%
Year-to-Date (YTD) Change
-24.10%
1-Year Change
-28.46%
3-Year Change
-67.55%
5-Year Change
-81.17%
All-Time (Max) Change
-81.17%

Contact Information

https://www.embecta.com
201 847 6880
300 Kimball Drive, Parsippany, NJ, 07054

Company Facts

20,000 Employees
IPO DateMar 22, 2022
CountryUS
Actively Trading

Frequently Asked Questions